Startups
BRAIN Biotech AG (“BRAIN”) is one of Europe's leading companies in the industrial (“white”) biotechnology. The company identifies previously unutilized powerful enzymes, microbial production organisms and natural substances from biological systems for industrial applications and healthcare.
BRAIN optimizes microbial production strains and develops efficient bioprocesses. With the BRAIN Engineered Cas (BEC) nuclease, the biotech company is developing a proprietary technology for genome editing and is continuously expanding it internationally into a powerful technology platform.
BRAIN optimizes microbial production strains and develops efficient bioprocesses. With the BRAIN Engineered Cas (BEC) nuclease, the biotech company is developing a proprietary technology for genome editing and is continuously expanding it internationally into a powerful technology platform.
Overview
Location
Germany, Hesse, Zwingenberg
Employees
201-500
Founded date
1993
Mentions in press and media 20
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 6, 2022 | Sweet proteins… finally ready for prime time? | Several companies are now deploying synthetic biology to ‘program’ microbes to express sweet proteins, from Roquette and Brain Biotech AG, who aim to take brazzein (an ultra-sweet protein found in oubli berries that they are producing vi... |
| Feb 17, 2022 | The Week in Agrifoodtech: Equip gets $58m to help manage eating disorders; Bowery acquires Traptic | This week, US telehealth startup Equip raised funds for its eating disorder management platform, while Danish agtech company Agreena secured $22.5 million to help farmers participate in carbon markets. In Asia, Next Gen Foods, the company b... |
| Feb 8, 2022 | BRAIN Biotech and Formo: Strategic partnership of European biotech experts for the production of animal-free milk protein | DGAP-News: BRAIN Biotech AG / Key word(s): Alliance BRAIN Biotech and Formo: Strategic partnership of European biotech experts for the production of animal-free milk protein 08.02.2022 / 08:15 The issuer is solely responsible for the conten... |
| Jan 19, 2022 | BRAIN Biotech : Investoren Präsentation Januar 2022 (nur in englisch verfügbar) | BRAIN Biotech AG Creating a #BiobasedFuture Investor Relations Presentation 2022 Zwingenberg, January 2022 Creating a #BiobasedFuture © BRAIN Biotech AG Zwingenberg Germany www.brain-biotech.com +49 (0) 6251-9331-0 1 Safe Harbor Statement T... |
| Jan 19, 2022 | BRAIN Biotech : Analysten Call Präsentation 12M (nur in englisch verfügbar) | BRAIN Biotech AG Creating a #BiobasedFuture Analyst Call 12M, FY 2020/21 Adriaan Moelker, CEO Lukas Linnig, CFO Zwingenberg, January 17th, 2022 Creating a #BiobasedFuture © BRAIN Biotech AG Zwingenberg Germany www.brain-biotech.com +49 (0) ... |
| Jan 10, 2022 | BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] | DGAP Preliminary announcement financial reports: BRAIN Biotech AG / Preliminary announcement on the disclosure of financial statements BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles ... |
| Sep 15, 2021 | BRAIN Biotech AG: BRAIN Biotech AG has successfully completed 10% cash capital increase from authorised capital with exclusion of statutory subscription rights | Disclosure of inside information in accordance with Article 17 MAR of the Regulation (EU) No 596/2014 NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA AND JAPAN OR AN... |
| Sep 15, 2021 | BRAIN Biotech : successfully placed new share capital for the financing of further growth initiatives | Around 10% new shares successfully placed Approximately EUR 19 million proceeds for growth The Management Board of BRAIN Biotech AG has, with the approval of the Supervisory Board, successfully completed the issue of approximately 1.99 mill... |
| Sep 15, 2021 | BRAIN Biotech : resolves on a 10% cash capital increase from authorised capital with exclusion of statutory subscription rights. | Disclosure of inside information in accordance with Article 17 MAR of the Regulation (EU) No 596/2014 NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA AND JAPAN OR AN... |
Show more
Reviews 0
FAQ about BRAIN Biotech AG
When was BRAIN Biotech AG founded?
BRAIN Biotech AG was founded in 1993.
What has the press written about BRAIN Biotech AG?
Parsers VC has collected 20 articles mentioning BRAIN Biotech AG, among them “Sweet proteins… finally ready for prime time?” (May 6, 2022) and “The Week in Agrifoodtech: Equip gets $58m to help manage eating disorders; Bowery acquires Traptic” (Feb 17, 2022).
Is BRAIN Biotech AG still active?
Yes, BRAIN Biotech AG is active; its latest activity on Parsers VC dates from Oct 24, 2024.